These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

999 related articles for article (PubMed ID: 29960142)

  • 21. Mendelian randomization in the bone field.
    Larsson SC; Michaëlsson K; Burgess S
    Bone; 2019 Sep; 126():51-58. PubMed ID: 30321669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insight into rheumatological cause and effect through the use of Mendelian randomization.
    Robinson PC; Choi HK; Do R; Merriman TR
    Nat Rev Rheumatol; 2016 Aug; 12(8):486-96. PubMed ID: 27411906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the Causal Relationship of Maternal Height on Birth Size and Gestational Age at Birth: A Mendelian Randomization Analysis.
    Zhang G; Bacelis J; Lengyel C; Teramo K; Hallman M; Helgeland Ø; Johansson S; Myhre R; Sengpiel V; Njølstad PR; Jacobsson B; Muglia L
    PLoS Med; 2015 Aug; 12(8):e1001865. PubMed ID: 26284790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reply to: Mendel's laws, Mendelian randomization and causal inference in observational data: substantive and nomenclatural issues.
    Mukamal KJ; Rimm EB; Stampfer MJ
    Eur J Epidemiol; 2020 Jul; 35(7):725-726. PubMed ID: 32529511
    [No Abstract]   [Full Text] [Related]  

  • 25. Estimating Marginal Healthcare Costs Using Genetic Variants as Instrumental Variables: Mendelian Randomization in Economic Evaluation.
    Dixon P; Davey Smith G; von Hinke S; Davies NM; Hollingworth W
    Pharmacoeconomics; 2016 Nov; 34(11):1075-1086. PubMed ID: 27484822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSF sTREM2 in neurological diseases: a two-sample Mendelian randomization study.
    Dong MH; Zhou LQ; Tang Y; Chen M; Xiao J; Shang K; Deng G; Qin C; Tian DS
    J Neuroinflammation; 2022 Apr; 19(1):79. PubMed ID: 35382840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Overview of Methods and Exemplars of the Use of Mendelian Randomisation in Nutritional Research.
    Bennett DA; Du H
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014914
    [No Abstract]   [Full Text] [Related]  

  • 28. Mendelian Randomization versus Path Models: Making Causal Inferences in Genetic Epidemiology.
    Ziegler A; Mwambi H; König IR
    Hum Hered; 2015; 79(3-4):194-204. PubMed ID: 26201704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mendelian randomisation - a genetic approach to an epidemiological method].
    Stensrud MJ
    Tidsskr Nor Laegeforen; 2016 Jun; 136(11):1002-5. PubMed ID: 27325033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Mendelian randomisation to assess potential benefit of clinical intervention.
    Burgess S; Butterworth A; Malarstig A; Thompson SG
    BMJ; 2012 Nov; 345():e7325. PubMed ID: 23131671
    [No Abstract]   [Full Text] [Related]  

  • 31. Using Mendelian Randomization to Improve the Design of Randomized Trials.
    Ference BA; Holmes MV; Smith GD
    Cold Spring Harb Perspect Med; 2021 Jul; 11(7):. PubMed ID: 33431510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Environmental factors and risk of multiple sclerosis: Findings from meta-analyses and Mendelian randomization studies.
    Belbasis L; Bellou V; Evangelou E; Tzoulaki I
    Mult Scler; 2020 Apr; 26(4):397-404. PubMed ID: 32249718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mendelian Randomization.
    Grover S; Del Greco M F; Stein CM; Ziegler A
    Methods Mol Biol; 2017; 1666():581-628. PubMed ID: 28980266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Causal effects of serum metabolites on amyotrophic lateral sclerosis: A Mendelian randomization study.
    Yang L; Lv X; Du H; Wu D; Wang M
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109771. PubMed ID: 31669200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials.
    Nitsch D; Molokhia M; Smeeth L; DeStavola BL; Whittaker JC; Leon DA
    Am J Epidemiol; 2006 Mar; 163(5):397-403. PubMed ID: 16410347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mendelian Randomization Analyses for Selection of Therapeutic Targets for Cardiovascular Disease Prevention: a Note of Circumspection.
    Rosenson RS; Koenig W
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):65-74. PubMed ID: 26797681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?
    Smith GD; Ebrahim S
    Int J Epidemiol; 2003 Feb; 32(1):1-22. PubMed ID: 12689998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mendelian Randomization Studies in Stroke: Exploration of Risk Factors and Drug Targets With Human Genetic Data.
    Georgakis MK; Gill D
    Stroke; 2021 Aug; 52(9):2992-3003. PubMed ID: 34399585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The genetics of vitamin D.
    Jiang X; Kiel DP; Kraft P
    Bone; 2019 Sep; 126():59-77. PubMed ID: 30316967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mendelian randomisation in cardiovascular research: an introduction for clinicians.
    Bennett DA; Holmes MV
    Heart; 2017 Sep; 103(18):1400-1407. PubMed ID: 28596306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.